Breast cancer at times is curable by surgery followed by chemotherapy and drug treatment if it is diagnosed in early stages.
Whereas, triple negative breast cancer is fatal and this is because drugs cannot destroy the cancer cells. There are no docking points in the cells for attachment with proteins that are, hormone estrogen, progesterone, and human growth factor receptor 2 called (HER2). Drugs use these points to attach and destroy cancer cells.
Immunotherapy is a great help, Dr. Sylvia Adams has studied about it. She made a research that some immune cells try to attack cancer cells and if we harness that, we could better treat it. She eliminated the confusion that whether immunotherapy aids in treating breast cancer or not. Women then do not develop any signs of cancer after the treatment. After that, the patients can be administered with drugs.
Though women try to get rid of triple negative breast cancer by chemotherapy and drugs, scientists researched that immunotherapy along chemotherapy is more efficient and it lowers death risk by 20% as compared to patients that are only been treated by chemotherapy.
Dr. Sylvia Adams says that chemotherapy combined with immunotherapy could save many lives from breast cancer. All that we need to do is target the cells at the right time and activate them to combine with different doses of chemotherapy and kill cancer cells.
Dr. Peter Schmid says that this discovery is a great achievement because it showed the importance of immunotherapy in fighting triple negative breast cancer. It has found that those patients who have protein PDL1 in their cancer cells, response to treatment in a better way. Litton is still approaching the idea that would be more beneficial to patients, and then they could be treated more efficiently.